2 Gene Therapy Stocks Oppenheimer Just Said Will 'Outperform'
May 22, 2015 at 09:10 AM EDT
In separate reports published Friday, Oppenheimer analysts initiated coverage of two gene therapy stocks - Cellectis SA (NASDAQ: CLLS) ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.